
Patent infringement: Pfizer convinces US Patent Office to cancel two Moderna coronavirus vaccine patents
Pfizer and BioNTech have separately challenged the validity of Moderna's patents in the court case, which also involves an additional patent not covered by Wednesday's decision.Pfizer and its German partner told the board in 2023 that the Moderna …